Oct 3 (Reuters) - Redcare Pharmacy NV RDC.DE :
* EQS-ADHOC: REDCARE PHARMACY ACHIEVES 81% GROWTH IN Q3 RX
SALES
IN GERMANY, 108% IN SEPTEMBER AND DECIDES TO ACCELERATE
MARKETING IN Q4 BASED ON VERY CONVINCING E-RX METRICS. FULL-YEAR
GUIDANCE UPDATED.
* REDCARE PHARMACY NV SEES FY TOTAL GROUP SALES OF EUR 2.35
TO EUR
2.5 BILLION (PREVIOUSLY, EUR 2.3 TO EUR 2.5 BILLION)
* REDCARE PHARMACY NV- SEES FY ADJUSTED EBITDA MARGIN OF
1.2-2.2%
(PREVIOUSLY 2-4%)
Source text for Eikon: ID:nEQ71thma
Further company coverage: RDC.DE
((Reuters.Briefs@thomsonreuters.com;))